Qube Research & Technologies (QRT)’s Definium Therapeutics DFTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.1M	Buy	682,901 +256,846	+60%	+$6.35M	0.03%	682
2026 Q1	$8.05M	Buy	+426,055	New	+$7.23M	0.01%	1406
2024 Q2	–	Sell	-116,327	Closed	-$1.09M	–	4402
2024 Q1	$1.09M	Buy	116,327 +22,678	+24%	+$129K	﹤0.01%	2094
2023 Q4	$343K	Buy	93,649 +84,644	+940%	+$255K	﹤0.01%	2510
2023 Q3	$28.2K	Buy	+9,005	New	+$37K	﹤0.01%	3040

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DFTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Definium Therapeutics (DFTX) stake by 60% in Q2 2026, buying an estimated $6.35M and bringing the position to 682,901 shares worth $32.1M. The position accounts for 0.03% of the portfolio, ranked #682.

Qube Research & Technologies (QRT) first reported a position in DFTX in Q3 2023 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Qube Research & Technologies (QRT) held 682,901 shares of Definium Therapeutics worth $32.1M as of Q2 2026.
Qube Research & Technologies (QRT) bought 256,846 Definium Therapeutics shares in Q2 2026, an estimated $6.35M.
Definium Therapeutics made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #682 holding.
Qube Research & Technologies (QRT) first reported a position in Definium Therapeutics in Q3 2023 and has held it in 5 quarters since.
361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.